A detailed history of Clari Vest Asset Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 61,448 shares of DVAX stock, worth $793,293. This represents 0.07% of its overall portfolio holdings.

Number of Shares
61,448
Previous 61,448 -0.0%
Holding current value
$793,293
Previous $690,000 0.87%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$10.73 - $12.58 $507,571 - $595,084
-47,304 Reduced 43.5%
61,448 $690,000
Q1 2024

May 06, 2024

BUY
$11.7 - $14.98 $131,449 - $168,300
11,235 Added 11.52%
108,752 $1.35 Million
Q4 2023

Feb 13, 2024

SELL
$13.09 - $14.98 $83,160 - $95,167
-6,353 Reduced 6.12%
97,517 $1.36 Million
Q3 2023

Nov 13, 2023

BUY
$12.64 - $14.99 $1,188 - $1,409
94 Added 0.09%
103,870 $1.53 Million
Q2 2023

Aug 14, 2023

SELL
$9.85 - $13.17 $735,410 - $983,285
-74,661 Reduced 41.84%
103,776 $1.34 Million
Q1 2023

May 08, 2023

SELL
$9.44 - $11.88 $877 - $1,104
-93 Reduced 0.05%
178,437 $1.75 Million
Q4 2022

Feb 14, 2023

SELL
$10.27 - $13.29 $11,009 - $14,246
-1,072 Reduced 0.6%
178,530 $1.9 Million
Q3 2022

Nov 10, 2022

BUY
$9.93 - $17.44 $742,376 - $1.3 Million
74,761 Added 71.31%
179,602 $1.88 Million
Q1 2022

May 04, 2022

BUY
$9.75 - $14.44 $22,854 - $33,847
2,344 Added 2.29%
104,841 $1.14 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $20.94 $285,749 - $454,335
21,697 Added 26.85%
102,497 $1.44 Million
Q3 2021

Nov 08, 2021

SELL
$9.16 - $19.83 $3,664 - $7,931
-400 Reduced 0.49%
80,800 $1.55 Million
Q1 2021

May 13, 2021

BUY
$4.57 - $11.18 $19,651 - $48,074
4,300 Added 5.59%
81,200 $798,000
Q4 2020

Feb 09, 2021

BUY
$3.73 - $5.6 $49,609 - $74,480
13,300 Added 20.91%
76,900 $342,000
Q3 2020

Nov 09, 2020

BUY
$4.32 - $11.7 $274,752 - $744,120
63,600 New
63,600 $274,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.